Monday, October 21, 2019

"Human Nutrition Market"2019-2025​ Making Food and Market Systems Work for Nutrition

The high growth in the Human Nutrition Market is mainly attributed to growing prevalance of diseases due to unhealthy eating, rising demand of fortified food products, rising disposable income, and growing health conciousness and demand for nutritional supplements. However, negative impact of false and misleading promotions and high cost of the dietary supplement products are the major factors expected to hinder the adoption of human nutrition products.
According to this latest publication from Meticulous Research , the global human Nutrition Market is expected to grow at a CAGR of 6.6% from 2019 to reach $465.4 billion by 2025.
“Human Nutrition Market by Type (Vitamin, Probiotics, Proteins, Carbohydrates, Fatty Acid, Minerals), Age (Adult, Childhood), Population (Pediatric, Geriatric, Maternal), and Application (Dietary Supplement, Functional Nutrients)- Global Forecast to 2025”
The global human nutrition market study presents historical market data in terms of value (2017 and 2018), estimated current data (2019), and forecasts for 2025-by type (vitamins, probiotics, proteins & amino acids, carbohydrates, fats & fatty acids, minerals), age group (childhood-adolescence, adult & parenthoods, seniors), population (pediatric population, geriatric population, maternal population, athletes population), and application (dietary supplements, functional nutrients, medical nutrition, infant nutrition, food & beverages). The study also evaluates industry competitors and analyzes the market at a regional and country level.
Hurry Up To Get Your Free Sample Report Now..!! https://www.meticulousresearch.com/request-sample-report/cp_id=5046
Based on type, the overall human nutrition market is segmented into vitamins, probiotics, proteins & amino acids, carbohydrates, fats & fatty acids, and minerals. Vitamins are estimated to hold the largest share of the overall human nutrition market in 2019. The large share of this market is mainly attributed to rising prevalence of vitamin deficiencies; huge demand of vitamin fortified food; growing health and wellness trends and awareness about preventive healthcare among consumers; and steady rise in the geriatric population in the developed economies (U.S., Europe, and Japan). However, fats and fatty acids segment is projected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to growing awareness about the role of fatty acids in determining health and nutritional well-being; technological advancements, such as microencapsulation; and growing demand from infant formula, dietary supplement, pharmaceutical, and clinical nutrition sectors.
Based on age group, childhood-adolescence segment is expected to command the largest share of the overall human nutrition market in 2019. The large share of this segment is mainly attributed to growing body needs in terms of energy, protein, and micronutrients for potential development and high rates of malnutrition and stunting among children.
Based on application, the global human nutrition market is mainly segmented into dietary supplements, functional nutrients, medical nutrition, infant nutrition, and food & beverages. Dietary supplements application is estimated to account for the largest share of the overall human nutrition market in 2019. Rapid urbanization, rising prevalence of diseases, and growing awareness regarding the health benefits of nutritional supplements among consumers are the key factors responsible for the large share of this segment in the market. However, infant nutrition segment is expected to grow at the highest CAGR during the forecast period, owing to rising disposable income of individuals, increasing health concerns among users regarding the development of babies, and growing population of working mothers.
This research report analyzes major geographies and provides a comprehensive analysis of North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is estimated to command the largest share of the global human nutrition market in 2019. The large share of this region is mainly attributed to rising prevalence of chronic diseases, including cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, obesity, and oral diseases; increasing focus on healthy lifestyle; well established nutraceutical and functional food industry; and growing health & wellness and clean label trends.
If any Inquire or share your questions before the purchasing this report -https://www.meticulousresearch.com/enquire-before-buying/cp_id=5046
The major players operating in the global human nutrition market are BASF SE (Germany), Abbott Laboratories (U.S.), Koninklijke DSM N.V. (The Netherlands), DuPont de Nemours, Inc. (U.S.), Chr. Hansen Holding A/S (Denmark), USANA Health Science, Inc. (U.S.), Pharmavite LLC. (U.S.), Nestle S.A. (Switzerland), Kerry Group PLC (Ireland), Glanbia PLC. (Ireland), Corbion N.V. (The Netherlands), ADM (U.S.), Bayer Health Care AG (Germany), Amway Corp.(U.S.), and Matsun Nutrition (U.S.) among others.
Key questions answered in the report:
The North American human nutrition market favors both larger and local manufacturers that compete in multiple segments
Who are the top competitors in this market and what strategies do they employ to gain shares?
What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
What strategies should new companies look to enter this market use to compete effectively?
What are the major drivers, restraints, and opportunities in the global human nutrition market?
Who are the major players in various countries and what share of the market do they hold?
What are the geographical trends and high growth regions/ countries?
Recent new product launches; partnerships, collaborations, and agreements; acquisitions & mergers; and expansions have taken place in the human nutrition market
What companies have recently merged/acquired in various countries across the globe and how will these unions affect the competitive landscape of the human nutrition market?
Which companies have created partnerships and how will these partnerships promote a competitive advantage?Who are the major players in the global human nutrition market and what share of the market do they hold?Who are the local emerging players in the human nutrition market and how do they compete with the global players?
Click here to Browse key industry insights spread across 384 pages with 433 market data tables & 74 figures & charts from the report
Related Report -
Alternative Protein Market by Stage/Type (Insect, Algae, Duckweed, Lab Meat, Pea, Rice, Potato, Corn, Soy, Wheat, Corn, Mycoprotein, Mushrooms), Application, and Geography - Global Forecast to 2025.
Plant Based Protein Market by Type (Soy Protein, Wheat Protein, Pea Protein, Potato Protein, Rice Protein, Corn Protein) and Application (Foods and Beverage, Animal Feed, Nutrition and Health Supplements, Pharmaceuticals) - Global Forecast to 2025
Share on Facebook Twitter Linkedin


Friday, October 11, 2019

Increasing Consumer’s Focus on Environmental sustainability and Animal Welfare Drives Growth of Meat Substitute Market - Global Forecast 2024



The factors such as rising consumer preference towards vegetarian or vegan diet across the globe, rising health concerns with consumption of meat products, and various health benefits are driving the growth of global meat substitutes market
Meat substitutes are plant or insect based products that look and taste like meat and could potentially play a key role in stimulating dietary change. On a global basis, plant based products are of immense importance and there is growing interest in its ability to meet rising demand for protein from non-meat sources, as high level of meat consumption is increasingly being criticized due to ethical, environmental, and social reasons. Also, due to the high cost and limited availability of animal proteins in several countries, consumer concerns over health benefits of animal-based proteins, and increasing flexitarianism, there is a growing focus on reducing meat products consumption. Meat substitutes have been identified as healthy sources of protein that, in comparison to meat, offer a number of social, environmental, and health benefits, and may play a key role in reducing meat intake.
Market Insights
Drivers
1 Urbanization, population growth, and a rising middle class lead to greater meat consumption
2 Increasing options for vegetarians and vegans
3 Rising tide of challenges for industrial meat industry
4 Enticing meat eaters to consume environmentally-friendly meat without compromising on taste
Restraints
1 Ill effects of consuming meat substitutes
2 Wide availability of meat products
Opportunities
1 Growth potential in emerging economies
Challenges
1 High cost of cultured meat
2 Genetically modified plant sources
Trends
1 Advances in agriculture technology and synthetic biology are enabling high-tech meatless products
For latest file format news and updates, Download free sample report 
Key Players
The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 5 years (2014-2018). The key players profiled in the global meat substitute market are Archer Daniels Midland Company, Dupont, The Nisshin Oillio Group, Sonic Biochem Limited, MGP Ingredients, Garden Protein International, Beyond Meat, Amy’s Kitchen, Quorn Foods, Morningstar Farms, Meatless, Vbites, Kreca Ento-Food BV, Entomo Farms, All Things Bugs, LLC, and Bitty Foods.
https://www.meticulousresearch.com/request-sample-report/cp_id=4969
Key questions answered in the report:
Growing demand for plant-based products to drive the growth of meat substitute market
How does the demand of plant-based products differ from insect- based products?Which are the high growth market segments in terms of source, category, and regions/ countries?
The North American meat substitute market favors both larger and local manufacturers that compete in multiple segments
Who are the top competitors in this market and what strategies do they employ to gain shares?Which market segments have the high potential for revenue expansion over the forecast period?What strategies should new companies looking to enter this market use to compete effectively?What are the major drivers, restrains, opportunities, challenges, and future potential in the global meat substitute market?Who are the major players in various countries and what share of the market do they hold?What are the geographical trends and high growth regions/ countries?
Recent new product launches and upgradation, agreements and partnerships, acquisitions and mergers, and expansions have taken place in the meat substitute market
What companies have recently merged/ acquired in various countries across the globe and how will these unions affect the competitive landscape of the meat substitute market?Which companies have created partnerships and how will these partnerships promote a competitive advantage?Who are the major players in the global meat substitute market and what share of the market do they hold?Who are the local emerging players in the meat substitute market and how do they compete with the global players?
Browse key industry insights & charts related to report @ https://www.meticulousresearch.com/request-sample-report/cp_id=4969
Share on Facebook Twitter Linkedin

Friday, October 4, 2019

TOP 10 COMPANIES IN ASIA HOSPITAL BEDS MARKET

Meticulous Research® –leading global market research company published a research report titled “Asia Medical/Hospital Beds Market by Product (Beds, Accessories), Area of Use (Critical, Bariatric, Med Surg, Pediatric, Maternal), Type of Care (Curative, Long term), and End User (Hospital, Homecare, Elderly) – Forecast to 2025”.
According to this latest publication from Meticulous Research®, Asia medical/hospital beds market is expected to grow at a CAGR of 5.8% from 2018 to reach $682.2 million by 2025. The Asia medical/hospital beds market is majorly driven by increasing elderly population coupled with growing prevalence of chronic diseases, rising number of hospitals, and growing medical tourism. However, factors such as growing preference for minimally invasive surgeries and decreasing number of beds in public hospitals are expected to hinder the growth of this market to some extent.

 
Key Market Segments to WatchAsia medical/hospital beds market study presents historical market data in terms of value (2016 and 2017), estimated current data (2018), and forecasts for 2025 -by product (medical/hospital beds, accessories), area of use (critical care, long-term care, bariatric care, med-surg, pediatric care, maternal care, and home care), type of care (curative care, long-term care, and rehabilitative care), technology (powered beds and manual beds), and end user (hospitals, elderly care settings, home care settings, and others). The study also evaluates industry competitors and analyzes the market at country level.
On the basis of area of use, the Asia medical/hospital beds market is segmented into critical care, long-term care, bariatric care, med-surg, pediatric care, maternal care, and home care. Critical care segment holds the largest share of the Asian medical/hospital beds market with the increasing number of accidents, growing incidence of infectious diseases, and rising prevalence of chronic diseases and fatal injuries in this region. However, home care market is expected to witness a rapid growth during the forecast period. The rapid growth of this market is primarily attributed to the rising healthcare expenditure, growing aging population coupled with increase in the incidence of chronic diseases, technological advancements such as wearable gadgets, and telehealth which has shifted the focus towards alternative methods of treatment such as home healthcare which is less expensive and effective.
On the basis of type of care, the Asia medical/hospital beds market is segmented into three major segments namely, curative care, long-term care, and rehabilitative care. Curative care segment accounted for the largest share of the Asia medical/hospital beds market in 2017. The large share of this segment is attributed to the growing inpatient population at the healthcare facilities across the Asia. However, long-term care segment is expected to witness a rapid growth during the forecast period.
This research report analyzes major geographies and provides comprehensive analysis of India, China, Japan, and Rest of Asia. The India accounted for the largest share of the Asia medical/hospital beds market with the rising prevalence of various chronic diseases; increase in the prevalence of cancers of digestive, urinary, respiratory, and reproductive systems; growth in per capita healthcare expenditure; increasing investments in the Indian healthcare industry; and expansion of private healthcare institutions in rural areas.
Key questions answered in the report-
  • Which are the high growth market segments in terms of product, area of use, type of care, technology, end user, and countries?
  • What is the historical market for medical/hospital beds across the Asia?
  • What are the market forecasts and estimates from the period 2018-2025?
  • What are the major drivers, restraints, opportunities, and trends in the Asia medical/hospital beds market?
  • Who are the major players in the Asia medical/hospital beds market and what share of the market do they hold?
  • Who are the major players in various countries and what share of the market do they hold?
  • How is the competitive landscape?
  • What are the recent developments in Asian medical/hospital beds market?
  • What are the different strategies adopted by the major players in the Asia medical/hospital beds market?
  • What are the geographic trends and high growth countries?
  • Who are the local emerging players in the Asian medical/hospital beds market and how do they compete with the other players?
Related Report -



x

Wednesday, September 18, 2019

A Look at the Factors Behind the Growth of Microfluidic Immunoassay Market -- Global Forecast 2019 to 2025

Factors such as increasing cancer incidence, rising cancer related healthcare expenditure, and demand for advanced cancer care options are driving the interventional oncology market, globally.

According to this latest publication from Meticulous Research®, the global microfluidic immunoassay market is expected to grow at a CAGR of 12.7% from 2019 to reach $2.01 billion by 2025. The growth of microfluidic immunoassay market is mainly attributed to greater benefits offered by LOC over conventional quantifiable technologies, growing need of POC in low-resource settings, increasing research activities in the field of microfluidic technology, high influx of venture capital funding for the development of LOC-based POC diagnostics, rapid decision making in emergency care, and rising incidence and prevalence of chronic diseases coupled with aging population. In addition, emerging economies and novel technologies such as paper-based microfluidics will further provide significant opportunities for the various stakeholders in this market. However, factors such as lengthy approval time for POC devices and reluctance of healthcare professionals to replace existing diagnostic platforms - are likely to hinder the market growth. On the other hand, selection of suitable substrate material for designing microfluidic chip; difficulty in up-scaling the process for mass production; and product-design and cost related challenges in the developing countries - are recognized as the major hurdles to overcome.

The global microfluidic immunoassay study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2025-by product type [lab on chip/ microfluidic diagnostic (microfluidic analyzers, microfluidic cartridges), other quantifiable point of care diagnostics (POC analyzers, reagent and assays)], technology [point of care lab on chip technology (electrochemical LOC POC technology, optical LOCPOC technology), quantitative nonLOC POC technology], application [cardiac biomarker detection (single biomarker assay, multiplexed panel assay), inflammatory biomarker detection, other biomarkers, and emerging biomarkers], and geography. The study also evaluates industry competitors and analyzes the market at regional and country level.
Based on technology, non-LOC POC technologies segment is estimated to command the largest share of the overall microfluidic immunoassay market in 2019. The large share of this segment is attributed to a greater adoption of these technologies - over the years - for wide range of diagnostic applications. However, LOC POC technology market is expected to grow at the fastest CAGR during the forecast period. This is mainly attributed to greater benefits offered by LOC over conventional POC diagnostic methods and growing research activities in this field - supported by private and public funding.
Based on application, the cardiac biomarker detection segment is estimated to hold the largest share of the overall microfluidic immunoassay market in 2019. The large share of the cardiac biomarker detection segment is primarily attributed to high prevalence of cardiovascular diseases, availability of large number of LOC-based products for cardiac biomarkers, and relatively greater adoption of these products among the end-users.
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), Latin America, and Middle East & Africa. North America commanded the largest share of the overall microfluidic immunoassay market, closely followed by the Europe, and Asia Pacific. However, Asia Pacific region is slated to register the highest growth during the forecast period, primarily due to accelerated growth of economies; lower regulatory hurdles; improving healthcare infrastructure; rising accessibility to healthcare services & innovative products; increasing incidence of infectious and non-communicable diseases with aging population; growing income level of middle class population; and continuous investment & focus of key medical device manufacturing giants in emerging Asian markets.
Scope of the Report:
Microfluidic Immunoassay Market by Product Type
  • Lab-on-chip/microfluidic diagnostics
    • Microfluidic Analyzers
    • MicrofluidicCartridges
  • Other Quantifiable POC diagnostics
    • POC Analyzers
    • Reagents and Assays
Microfluidic Immunoassay Market by Technology
  • Point of Care Lab on Chip Technology
    • Electrochemical LOC POC Technology
    • Optical POC LOC Technology
  • Non Lab on Chip Point of Care Technology
Microfluidic Immunoassay Market by Application
  • Cardiac Biomarker Detection
    • Single Biomarker Assay
      • Troponin
      • Brain Natriuretic Peptide (BNP)
      • Other Cardiac Biomarkers
    • Multiplexed Panel Assay
  • Inflammatory Biomarker Detection
  • Other Biomarkers
  • Emerging Biomarkers
Microfluidic Immunoassay Market by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa
Key questions answered in the report-
  • Which are the high growth market segments in terms of product type, technology, application, and region/countries?
  • What was the historical market for microfluidic immunoassay across the globe?
  • What are the market forecasts and estimates for the period 2019–2025?
  • What are the major drivers, restraints, challenges, and opportunities in the global microfluidic immunoassay market?
  • Who are the major players in the global microfluidic immunoassay market?
  • How is the competitive landscape and who are the market leaders in the global microfluidic immunoassay market?
  • What are the recent developments in the global microfluidic immunoassay market?
  • What are the different strategies adopted by the major players in the global microfluidic immunoassay market?
  • What are the geographical trends and high growth regions/ countries?


Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research